Emergent BioSolutions
EBS
#6766
Rank
NZ$1.09 B
Marketcap
NZ$20.61
Share price
-1.24%
Change (1 day)
37.40%
Change (1 year)

Emergent BioSolutions (EBS) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : NZ$1.52 Billion

According to Emergent BioSolutions 's latest financial reports the company's total liabilities are NZ$1.52 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Emergent BioSolutions - Total liabilities on balance sheet (from 2004 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31NZ$1.60 B-13.37%
2023-12-31NZ$1.85 B-33.74%
2022-12-31NZ$2.80 B42.14%
2021-12-31NZ$1.97 B-0.98%
2020-12-31NZ$1.99 B8.21%
2019-12-31NZ$1.83 B1.26%
2018-12-31NZ$1.81 B717.05%
2017-12-31NZ$0.22 B-58.81%
2016-12-31NZ$0.53 B-2.13%
2015-12-31NZ$0.55 B12.1%
2014-12-31NZ$0.49 B194.12%
2013-12-31NZ$0.16 B12.7%
2012-12-31NZ$0.14 B-10.99%
2011-12-31NZ$0.16 B1.49%
2010-12-31NZ$0.16 B18.3%
2009-12-31NZ$0.13 B-11.86%
2008-12-31NZ$0.15 B17.93%
2007-12-31NZ$0.13 B-5.66%
2006-12-31NZ$0.14 B138.47%
2005-12-31NZ$59.39 M-8.08%
2004-12-31NZ$64.61 M
2002-12-31NZ$35.6 M-74.38%
2001-12-31NZ$0.13 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Merck
MRK
NZ$134.49 B 8,737.68%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
NZ$48.71 M-96.80%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$106.16 B 6,876.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
NZ$86.74 M-94.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$200.31 B 13,062.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$56.47 B 3,611.10%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Soligenix
SNGX
NZ$6.4 M-99.58%๐Ÿ‡บ๐Ÿ‡ธ USA